Aytu Biopharma (AYTU) Other Non-Current Assets (2013 - 2026)

Aytu Biopharma (AYTU) has 14 years of Other Non-Current Assets data on file, last reported at $556000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $556000.0 in Q1 2026; TTM through Mar 2026 was $556000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.2 million, up 2636.36% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $556000.0, down from $738000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for AYTU reached as high as $2.5 million in Q2 2023 and fell as low as $44000.0 in Q2 2024.
• Historically, Other Non-Current Assets has averaged $905428.6 across 5 years, with a median of $825000.0 in 2022.
• Across the five-year window, Other Non-Current Assets plunged 98.27% in 2024 and surged 2636.36% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $821000.0 in 2022, then grew by 10.48% to $907000.0 in 2023, then plunged by 95.15% to $44000.0 in 2024, then soared by 1577.27% to $738000.0 in 2025, then fell by 24.66% to $556000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $556000.0 in Q1 2026, $738000.0 in Q4 2025, and $939000.0 in Q3 2025.